Showing 791-800 of 19240 results for "".
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
https://reachmd.com/clinical-practice/nephrology/the-impact-of-finerenone-plus-empagliflozin-on-hyperkalemia-in-the-confidence-trial/39960/Join Dr. Agarwal from the Kidney Meeting 2025 in Houston as he interprets key findings regarding hyperkalemia from the CONFIDENCE trial.The CONFIDENCE Trial: Data Insights
https://reachmd.com/cme/ERA-2025-nsMRA-CKM/the-confidence-trial-data-insights/35845/Dr. Hiddo Heerspink shares CONFIDENCE trial insights from ERA 2025 showing finerenone + empagliflozin lowers albuminuria in patients with CKD and T2D.Unmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
https://reachmd.com/programs/living-rheum/unmasking-igg4-related-disease-best-practices-for-accurate-diagnosis-and-optimal-care/32788/IgG4-related disease presents significant diagnostic challenges with diverse symptoms across organ systems. Dr. Matthew Baker, Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Founder and Co-Director of the Stanford Multidisciplinary SarcoidosProstatic Cryosurgery and Robotic Prostatectomy
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/prostatic-cryosurgery-and-robotic-prostatectomy/4013/Newer options for treating prostate cancer include cryosurgery and robotic prostatectomy. What does each of these methods involve and how can we determine the best treatment for our patients? Dr. David I. Lee, assistant professor of surgery at Penn Medicine, explores the advantages, risks, and outcoUnleashing Femspan
https://reachmd.com/programs/modern-aesthetics/Unleashing-Femspan/32718/Women are born with unique biological advantages favoring longevity. I have coined this phenomenon the “Female Longevity Factor.” However, offsetting these advantages are potential risks related to lifestyle and environmental exposures. By proactively addressing the so-called epigenetic effects, a pIncorporating Nutrition Into Clinical Practice
https://reachmd.com/programs/focus-on-nutrition-and-nutrition-science/incorporating-nutrition-into-clinical-practice/4442/Poor nutrition and lifestyle habits are common drivers of chronic health problems such as obesity, heart disease, and diabetes. What do physicians and other healthcare providers need to know about providing effective lifestyle changes for their patients, as well as for themselves? Host Amy Hendel spGeneral Medical Conditions and Depression
https://reachmd.com/programs/clinicians-roundtable/general-medical-conditions-and-depression/1915/Is there a relationship between cardiovascular disease and depression? Can depression influence the treatment of other conditions such as diabetes, stroke and cancer? Host Dr. Leslie Lundt is joined by Dr. Jill Warnock to discuss the interplay between medical illness and depression.A Look at Healthcare Policy with Congressman Kirk
https://reachmd.com/programs/clinicians-roundtable/a-look-at-healthcare-policy-with-congressman-kirk/1857/Congressman Mark Kirk, vice chair of the congressional diabetes caucus speaks with host Dr. Mark Nolan Hill about various healthcare policy topics including SCHP and Insuring the uninsured and underinsured.New Guidelines for Post Prandial Glucose
https://reachmd.com/programs/clinicians-roundtable/new-guidelines-for-post-prandial-glucose/1741/Dr. Shira Johnson interviews Dr. Antonio Ceriello from the International Diabetes Federation to share with us the new guidelines which will impact post prandial glucose control in your patients."Overcoming Obamacare:" Health Policy Perspectives with Author Philip Klein
https://reachmd.com/programs/voices-from-american-medicine/overcoming-obamacare-health-policy-perspectives-author-philip-klein/7284/“One cannot understand policy without appreciating the philosophy that is driving it.” That’s a passage taken from author Philip Klein's book, Overcoming Obamacare: Three Approaches to Reversing the Government Takeover of Health Care. Mr. Klein is commentary editor of the Washington Examiner, where